UBS Group’s Amplify Seymour Cannabis ETF CNBS Stock Holding History
Bought
Maintained
Sold
Other funds holding CNBS
TI
OMC
MFG
FLP
AWM
UBS Group's CNBS Position: Q2 2026 in Review
UBS Group reduced its Amplify Seymour Cannabis ETF (CNBS) stake by 94% in Q2 2026, selling an estimated $18.4K and leaving 44 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #9594.
UBS Group first reported a position in CNBS in Q1 2020 and has held it in 17 quarters since. The position peaked at $149K in Q3 2025. 16 funds tracked by Wall St. Rank hold CNBS as of Q2 2026.
- UBS Group held 44 shares of Amplify Seymour Cannabis ETF worth $1.28K as of Q2 2026.
- UBS Group sold 670 Amplify Seymour Cannabis ETF shares in Q2 2026, an estimated $18.4K.
- Amplify Seymour Cannabis ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9594 holding.
- UBS Group first reported a position in Amplify Seymour Cannabis ETF in Q1 2020 and has held it in 17 quarters since.
- UBS Group's Amplify Seymour Cannabis ETF position peaked at $149K in Q3 2025.
- 16 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.